| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 75.06B | 61.43B | 59.35B | 54.38B | 49.96B |
| Gross Profit | 18.97B | 32.87B | 26.09B | 24.23B | 27.92B |
| EBITDA | 48.79B | 41.54B | 40.02B | 37.06B | 34.52B |
| Net Income | 30.79B | 25.14B | 23.46B | 22.37B | 21.61B |
Balance Sheet | |||||
| Total Assets | 899.89B | 878.18B | 881.22B | 803.38B | 752.32B |
| Cash, Cash Equivalents and Short-Term Investments | 30.21B | 34.70B | 33.30B | 32.54B | 35.00B |
| Total Debt | 362.30B | 333.30B | 333.30B | 309.10B | 282.50B |
| Total Liabilities | 401.57B | 369.63B | 368.63B | 337.07B | 313.48B |
| Stockholders Equity | 498.32B | 508.54B | 512.59B | 466.31B | 438.84B |
Cash Flow | |||||
| Free Cash Flow | -506.39M | 37.69B | -60.83B | -29.51B | -30.65B |
| Operating Cash Flow | 43.72B | 40.51B | 36.39B | 35.80B | 34.22B |
| Investing Cash Flow | -53.57B | -2.54B | -94.50B | -63.85B | -63.05B |
| Financing Cash Flow | -12.02B | -29.20B | 52.23B | 26.31B | 35.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥269.90B | 19.83 | 5.78% | 5.26% | 12.81% | 1.32% | |
68 Neutral | ¥640.02B | 21.26 | ― | 4.86% | ― | ― | |
66 Neutral | ¥267.48B | 10.83 | 8.18% | 3.87% | 27.77% | 14.16% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥190.08B | 12.06 | ― | 4.68% | 22.29% | 0.88% | |
63 Neutral | ¥744.11B | 25.28 | ― | 4.10% | 12.04% | 12.83% |